Background Only a few studies have reported treatment options for stenosis after endoscopic submucosal dissection (ESD) for gastric neoplasms. This study aimed to identify the risk factors for and evaluate the management of stenosis after ESD for gastric epithelial neoplasms in the cardia and antrum.
Introduction
Although endoscopic resection is a useful treatment option for gastric epithelial neoplasms with a negligible risk of lymph node metastasis, its indication was previously limited to small (\2 cm) intramucosal lesions without ulceration owing to the technical limitations of conventional endoscopic mucosal resection [1] [2] [3] . To overcome this limitation, endoscopic submucosal dissection (ESD) was developed to enable en bloc resection of gastric neoplasms irrespective of size or ulceration within the lesion, resulting in a precise histological assessment of the resected specimen and reducing the risk of local recurrence [4] [5] [6] . Moreover, based on the findings of a retrospective analysis of lymph node metastasis in a large number of surgical cases with early gastric cancer (EGC) [7] , indications for ESD have been expanded to larger and ulcerative lesions [8] . However, the use of ESD for extensive resection of large lesions, particularly those in the cardia or antrum, often leads to gastric stenosis, thereby decreasing the patient's quality of life [9] [10] [11] [12] . Although a few studies have reported that post-ESD stenosis can be well managed by endoscopic balloon dilation (EBD), local steroid injection into the post-ESD ulcer, mucosal incision with steroid injection, or oral administration of steroids [9] [10] [11] [12] [13] [14] [15] , the optimal management for post-ESD stenosis remains controversial because of the high risk of complications associated with EBD, such as bleeding and perforation; also, the number of studies (all single center) investigating the efficacy of local injection and oral administration of steroids is limited, although several publications report good results with esophageal stenosis. Consequently, the present study aimed to identify risk factors and evaluate management options for stenosis after ESD for gastric epithelial neoplasms in the cardia and antrum, which are particularly susceptible to stenosis after gastric ESD.
Patients and methods

Patients
A total of 1218 consecutive patients with 1447 gastric epithelial neoplasms, including EGCs and adenomas, underwent ESD at Tonan Hospital from June 2004 to November 2015. The locations of the lesions in the stomach were 288 in the upper third, 507 in the middle third, and 652 in the lower third. Cardiac resection was defined as extending to esophagogastric junction, and antral resection was defined as localized to the lower third of the stomach, including the gastric angulus and pyloric ring, except for resections that extended to the gastric body. Ninety-one patients with 99 lesions underwent cardiac resection, and 570 patients with 636 lesions underwent antral resection. Among these patients, those with lesions in the gastric tube (n = 5), who underwent additional surgery owing to noncurative ESD (n = 67), with a lesion that could not be resected (n = 1), and who did not undergo initial follow-up esophagogastroduodenoscopy (EGD) after ESD at our hospital (n = 54) were excluded. In addition, patients with multiple lesions in the same region (n = 55) were excluded. Finally, 47 patients with 47 lesions were enrolled in the cardiac resection group and 432 patients with 432 lesions were involved in the antral resection group (Fig. 1) . All patients were ESD naïve.
The medical records of patients in both groups were retrospectively reviewed, and data pertaining to clinicopathological features, endoscopic images, and endoscopic and histopathological reports were extracted. Written informed consent was obtained from either the patients or their families before ESD. The study protocol was approved by the Institutional Review Board of Tonan Hospital and conducted in accordance with the Declaration of Helsinki.
Indications for ESD
Lesions that clinically fulfilled the absolute or expanded indication criteria according to the Japanese gastric cancer treatment guidelines of 2010 [8] were targeted for ESD. The curability of the resected specimens was also pathologically assessed based on the Japanese gastric cancer treatment guidelines of 2010 [8] . The ESD procedure was performed using an insulated-tipped knife (IT knife, KD-610L; Olympus, Tokyo, Japan) or an IT knife-2 (KD-611L; Olympus), as previously reported [16] [17] [18] .
Post-ESD stenosis
Post-ESD stenosis was defined as a narrowing of the stomach lumen to the extent that a standard 10-mm-diameter endoscope could not be smoothly passed through without endoscopic dilation. Risk factors for post-ESD stenosis in both the cardiac and antral resection groups were analyzed with regard to age, sex, macroscopic type of the lesion, findings of ulceration within the lesion, maximum diameter of the resected specimen, circumferential extent of the mucosal defect, longitudinal extent of the mucosal defect, location of the mucosal defect center, occurrence of post-ESD bleeding, and perforation during ESD. In addition, the incidence of resection extending to the pyloric ring was examined in the antral resection group.
All post-ESD bleeding episodes were successfully treated by endoscopic coagulation, and all perforations could be managed by conservative therapy.
Management for post-ESD stenosis
EBD was performed for the management of post-ESD stenosis, and a 12-to 15-mm, 15-to 18-mm, or 18-to 20-mm controlled radial expansion balloon dilator (CRE Wire-Guided Balloon Dilation Catheter; Boston Scientific, Tokyo, Japan) with an adjustable diameter was used for dilation. EBD was then classified as either ''conventional EBD'' or ''prophylactic EBD''. Conventional EBD was carried out for patients who suffered from any clinical symptoms after development of post-ESD stenosis, and prophylactic EBD was generally performed for patients at a high risk of development of post-ESD stenosis resulting from wide resection extending to the entire circumference or sub-circumference of the gastric lumen. Conventional EBD was routinely performed once a week, but also as needed for relief of symptoms related to stenosis, such as dysphagia, nausea, and vomiting, until a standard endoscope could be passed through the stenotic lumen without any resistance. In general, prophylactic EBD was commenced within approximately 2-3 weeks after the ESD and repeated once a week or per 2 weeks until the mucosal defect was completely healed without gastric stenosis. If the patients experienced any symptoms related to stenosis despite prophylactic EBD, EBD was also performed as necessary for the management of post-ESD stenosis.
The clinical course of patients following EBD was compared relative to the number of EBD sessions, the period EBD was required, and complications associated with EBD between patients with conventional EBD and those with prophylactic EBD. Cases of perforation during EBD were excluded from the analysis of the median number of EBD sessions and period of EBD. Post-EBD bleeding was defined as bleeding from the dilated site with occurrence of hematemesis and/or melena after a procedure requiring hemostatic treatment such as endoscopic clipping or coagulation by hemostatic forceps. Perforation was diagnosed endoscopically during the procedure or detected as pneumoperitoneum either by abdominal computed tomography or by roentgenography after the procedure.
Statistical analysis
Data were analyzed using the Fisher's exact test, chisquare test, or Student's t test as appropriate for univariate analysis. The categorical variables with p \ 0.05 in the univariate analysis, except for age and sex, were examined in multivariate analysis using logistic regression models. Odds ratios (OR) and 95% confidence intervals (CI) were calculated by logistic regression analysis to identify risk factors associated with post-ESD stenosis. A value of p \ 0.05 was considered to indicate statistical significance.
Results
Patient characteristics (Table 1) The mean patient age was 72.8 years (range, 35-88 years) in the cardiac resection group and 71.5 years (range, 34-91 years) in the antral resection group. The male/female ratio was 2.4:1 (33:14) and 2.5:1 (309:123) in the cardiac and antral resection groups, respectively. The mean tumor size was 21.9 mm (range, 4-68 mm) in the cardiac resection group and 16.6 mm (range, 1-80 mm) in the antral resection group.
Risk factors for post-ESD stenosis (Tables 2, 3)
Post-ESD stenosis occurred in 10 (21.3%) of the 47 cardiac resection cases and 14 (3.2%) of the 432 antral resection cases. All cases with post-ESD stenosis in the antrum and 7 of 10 in the cardia were diagnosed with adenocarcinoma.
For univariate analysis, the risk factors associated with post-ESD stenosis were maximum diameter of the resected specimen more than 50 mm, circumferential extent of the mucosal defect more than three fourths, and longitudinal extent of the mucosal defect more than 50 mm in both the cardiac and antral resection groups. Moreover, resection extending to the pyloric ring and post-ESD bleeding were also significant risk factors in the antral resection group. However, for multivariate analysis, only the circumferential extent of the mucosal defect of more than three fourths was a significant risk factor associated with post-ESD stenosis in both the cardiac and antral resection groups (OR Prophylactic EBD was performed in 3 of 10 patients with post-ESD stenosis in the cardiac resection group and 4 of 14 with post-ESD stenosis in the antral resection group. There were no significant differences with respect to the patient's background between patients with conventional EBD and those with prophylactic EBD in the cardiac and antral stenosis cases, respectively. In the cardiac stenosis cases, the number of total EBD sessions and the period required for EBD tended to be greater and longer, respectively, in patients with prophylactic EBD compared with those with conventional EBD. In the antral stenosis cases, however, the period of EBD tended to be shorter in patients with prophylactic EBD compared with those with conventional EBD, although the cases of perforation during EBD were excluded from analysis.
With regard to complications, post-EBD bleeding occurred in one (10%) of the cardiac stenosis cases and one (7.1%) of the antral stenosis cases, which were successfully treated by endoscopic coagulation. Although one of the post-EBD bleeding cases was an extremely aged patient who took daily low-dose aspirin for cardiovascular disease, EBD was performed without discontinuation of the use of antithrombotic agent during and after the procedure because of the high risk of thromboembolism. Perforation during EBD occurred in two (14.3%) of the antral stenosis cases and none of the cardiac stenosis cases. All perforations occurred during the first EBD, and a 15-to 18-mm balloon dilator was used in one patient and an 18-to 20-mm dilator in another. These patients underwent emergency open surgery because of the large amount of food retained in their stomachs. In addition, all complications were observed in the patients with conventional EBD and none in patients with prophylactic EBD.
Although most of the patients with post-ESD stenosis experienced symptoms related to the stenosis, such as dysphagia, abdominal fullness, nausea, and/or vomiting, EBD contributed to symptomatic relief as well as improvement of stenosis in every patient, except for the cases of perforation.
Discussion
The incidence of post-ESD stenosis has been reported to be 1.9-2.5% of all gastric ESD cases, including 0-17% in the cardia and 3.7-18.8% in the antrum or prepylorus [9] [10] [11] [12] ; ESD endoscopic submucosal dissection Risk factors and management for gastric stenosis after endoscopic submucosal dissection for… 693 these findings were similar to the results of our study. Although the risk factors related to the development of post-ESD stenosis are reported to be a circumferential mucosal defect of extent more than three fourths and a longitudinal mucosal defect of extent greater than 50 mm in length in both cardiac and pyloric resections [10] , these factors were shown as the result of univariate analysis, and confounding factors were not adjusted by the multivariate analysis. In the present study, the results of multivariate analysis showed that a wide resection of more than three fourths of the circumferential extent was the sole significant risk factor for the development of post-ESD stenosis in both cardiac and antral resection groups (although a longitudinal mucosal defect of extent of greater than 50 mm in length was also significant in the univariate analysis). Furthermore, ''pyloric resection'' was defined as located less than 10 mm from the pyloric ring and ''cardiac resection'' as located in the squamocolumnar junction in the previous study [10] ; these definitions were somewhat different from those of the present study. These differences in methods of analysis (univariate or multivariate analysis) and definitions might result in the different risk factors related to the development of post-ESD stenosis. As described in previous reports, although EBD is often performed for post-ESD stenosis, it carries some risk of complications, such as post-EBD bleeding and perforation. Post-EBD bleeding does not occur very frequently and can be well managed endoscopically [19] . By contrast, the incidence of perforation is relatively high, at 7.8-50% [9, 11, 12] , and often requires emergency surgery (although one case study [10] reported no complications). In the present study, post-EBD bleeding occurred in one cardiac stenosis case (10%) and in one antral stenosis case (7.1%), both of which were successfully treated by endoscopic coagulation. However, EBD should be carefully performed for patients with regular use of antithrombotic agents ESD endoscopic submucosal dissection because EBD is proposed as a high-risk procedure for bleeding according to the Japan Gastroenterological Endoscopy Society guidelines [20] . Conversely, perforation during EBD occurred in two patients (14.3%) in the antrum, and all were repaired by emergency surgery. Notably, all complications occurred in the patients undergoing conventional EBD, and no complications were associated with prophylactic EBD in this study; this finding suggests that prophylactic EBD could be a feasible procedure for the management of post-ESD stenosis, although repetitive EBD may be required, particularly in cardiac stenosis cases. It was reported that the narrowest ulcerative area, which was thought to be fragile because of the lack of the mucosal and submucosal layer, would receive the strongest pressure irrespective of balloon diameter [19] , and therefore prophylactic EBD could avoid overpressure to the stenotic area, resulting in fewer complications.
The curability of ESD is based on pathological evaluation of the resected specimen because it is sometimes difficult to precisely assess the depth of tumor invasion before ESD, although lesions greater than 30 mm were significantly associated with an increased risk of submucosal invasion [21] . If the lesion is pathologically diagnosed as having a risk of lymph node metastasis, additional gastrectomy with lymph node dissection is principally required. Therefore, the indication for ESD of large EGC, which requires a wide resection with the risk of the development of post-ESD stenosis, should be carefully decided in terms of invasiveness and cost-effectiveness because of the possibility of frequent EBD, complications of EBD, and additional surgery. In recent years, laparoscopic distal gastrectomy (LDG) for EGC has been widely accepted as a less invasive surgery than open distal gastrectomy [22] [23] [24] , and there are no significant differences in long-term clinical outcomes between the two surgical procedures [25] [26] [27] . EBD in the lower stomach has been reported to be associated with a substantial risk of perforation if post-ESD stenosis developed [19] . Similarly, in the present study, all perforations during EBD occurred in antral cases and required emergency open surgery, although LDG could have been performed if surgical treatment had been initially selected. Therefore, LDG may be also considered a treatment option for gastric antral neoplasms, particularly EGCs, which require a wide resection, leading to the development of post-ESD stenosis.
With regard to the limitations of this study, the results were retrospectively obtained at a single center and the number of cases with post-ESD stenosis was relatively small (specifically, patients with prophylactic EBD). Moreover, this study was not randomized or controlled, as Longitudinal extent of mucosal defect (mm) 0.17 0.13
Resection over pylorus ring 0.28
EBD endoscopic balloon dilation Table 5 Treatment outcomes for stenosis after gastric ESD Cardiac stenosis (n = 10) Antral stenosis (n = 14)
Prophylactic EBD Prophylactic EBD the aim was to compare prophylactic EBD with conventional EBD for the management of post-ESD stenosis. Despite these limitations, because there have been no previously published reports of the effectiveness of prophylactic EBD for the management of stenosis after gastric ESD, we therefore believe that this study is meaningful. We hope that a multicenter study incorporating a large number of cases is conducted in the near future to establish an optimal management strategy for post-ESD stenosis.
In conclusion, a wide resection of more than three fourths of the circumferential extent was the sole significant risk factor for the development of post-ESD stenosis in both cardiac and antral resections. Prophylactic EBD may be a promising procedure for the management of post-ESD stenosis. Table 6 Details of complication cases related to endoscopic balloon dilation after ESD Sex Age Risk factors and management for gastric stenosis after endoscopic submucosal dissection for… 697
